|
|
| |
| |
Your access to vital information on head and neck cancers is now easier, with comprehensive coverage of this topic at your fingertips. ASCO has gathered and synthesized data on head and neck cancers from a multitude of key sources, including the Journal of Clinical Oncology and other ASCO publications, the Virtual Meeting, and more. Experience the ease of finding in-depth information on head and neck cancers topics, and visit often to remain current with timely updates.
|
|
| |
|
JCO Highlighted Head and Neck Cancers Articles
|
Last Updated: October 20, 2009
|
 |
|
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
(JCO, August 2009)
|
|
|
Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024
(JCO, October 2009)
|
|
|
Phase I Study of C-TPF in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
(JCO, September 2009)
|
|
|
Randomized Trial of 13-cis Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral Premalignancy
(JCO, February 2009)
|
|
|
Prospective Risk-Adjusted [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography Assessment of Radiation Response in Head and Neck Cancer
(JCO, May 2009)
|
|
|
|
|
Medline Latest Head and Neck Cancers Articles
|
Last Updated: November 1, 2009
|
|
|
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.
(J Clin Oncol, 2009 Aug)
|
|
|
Electrochemical sensor for multiplex biomarkers detection.
(Clin Cancer Res, 2009 Jul)
|
|
|
Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.
(Clin Cancer Res, 2009 Apr)
|
|
|
Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.
(Clin Cancer Res, 2009 Apr)
|
|
|
Telomerase-specific virotheranostics for human head and neck cancer.
(Clin Cancer Res, 2009 Apr)
|
|
|
|
|
Virtual Meeting
|
|
|
View head and neck cancer track presentations from the 2008 ASCO Annual Meeting. In addition, search head and neck cancer presentations from previous meetings.
|
|
|
|
Abstracts
|
|
|
Search the 2008 head and neck cancer abstracts as well as abstracts back through the 2000 Annual Meeting.
|
|
|
|
Educational Book
|
|
|
Find head and neck cancer manuscripts grouped into areas of interest, or search the 2002-2009 Educational Books archive.
|
|
|
|
Cancer.Net
|
|
|
Find information and resources to support your patients living with head and neck cancers
|
|
|
|
|
|
|
|
 |
|
2010 ASCO Annual Meeting
McCormick Place – Chicago, IL
June 4 - 8, 2010
|
|
This online resource is supported by:
|
|
|
|
|
|
